Zoetis ZTS U.S. — Cost of Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Zoetis in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Zoetis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zoetis's u.s. — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zoetis's U.S. — cost of sales?
- Zoetis (ZTS) reported U.S. — cost of sales of $194M in Q1 2026.
- How has Zoetis's U.S. — cost of sales changed year-over-year?
- Zoetis's U.S. — cost of sales decreased by 2.5% year-over-year, from $199M to $194M.
- What is the long-term trend for Zoetis's U.S. — cost of sales?
- Over 4 years (2021 to 2025), Zoetis's U.S. — cost of sales has grown at a 1.7% compound annual growth rate (CAGR), from $788M to $842M.
- What does U.S. — cost of sales mean?
- This represents the direct costs attributable to the production and distribution of goods sold within the United States segment. It includes raw materials, manufacturing labor, and logistics expenses required to bring animal health products to market.